MedTrace Logo

Study Comparing Atomizerd Midazolam & Fentanyl and Dexmedomidine for Procedural Sedation in Adult and Pediatric Patient (2 to 60 Years Old)

NCT07166666 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 128

Last updated 2025-09-10

No results posted yet for this study

Summary

To evaluate the depth of sedation, as well as onset, and recovery times, satisfaction of sedation , adverse events associated with Atomized Midazolam \& Fentanyl and Dexmedetomidine during procedural sedation in a diverse population spanning from 2 to 60 years old at these three prominent Omani healthcare facilities.

Conditions

  • Sedation
  • Analgesia Assessment

Interventions

DEVICE

atomizer

use atomizer to provide the medication in procedure sedation

DRUG

rescue medication

will be used as rescue if the atomizer medication not fully sedated

DRUG

Midazolam

Intranasal administration for procedural sedation.

DRUG

fentanyl

Intranasal administration for procedural sedation.

DRUG

Dexmedetomidine

Intranasal administration for procedural sedation.

DRUG

Placabo

use atomizer to provide the placebo in procedure sedation

Sponsors & Collaborators

  • Oman Medical Speciality Board

    lead OTHER_GOV

Principal Investigators

  • saud al bulashi, MD · MOH/ oman

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-01
Primary Completion
2026-09-30
Completion
2026-10-01

Countries

  • Oman

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07166666 on ClinicalTrials.gov